Objectives:

1. Define the 2018 research framework for the operational definition of Alzheimer's disease.

2. Identify biomarkers for amyloid, tau and neuronal damage

3. Recognize the appropriate use criteria of Alzheimer's disease biomarkers in clinical practice

Session date: 
04/19/2023 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center-D1.602
United States
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.